raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:324525

Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation

Synonyms: Hypertrophic cardiomyopathy with kidney anomalies due to mtDNA mutation · Hypertrophic cardiomyopathy with renal anomalies due to mitochondrial DNA mutation

Type
Disease
Group
Disorder
Inheritance
No data available
Age of onset
Infancy, Neonatal
Status
active

A mitochondrial oxidative phosphorylation disorder characterized by hypertrophic and dilated cardiomyopathy, failure to thrive, myopathy with generalized hypotonia and increased creatine kinase, developmental delay and/or regression with cerebral atrophy on brain MRI, renal manifestations including chronic renal failure, renal tubular acidosis and lactic acidosis. Additional clinical features include seizures and respiratory failure.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enHypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutationHypertrophic cardiomyopathy with kidney anomalies due to mtDNA mutation · Hypertrophic cardiomyopathy with renal anomalies due to mitochondrial DNA mutation
frCardiomyopathie hypertrophique avec anomalies rénales dues à une mutation de l'ADN mitochondrialCardiomyopathie hypertrophique avec anomalies rénales dues à une mutation de l'ADNmt
deHypertrophe Kardiomyopathie mit Nierenanomalien durch mitochondriale DNA-MutationHypertrophe Kardiomyopathie mit renalen Anomalien durch mtDNA-Mutation
esMiocardiopatía hipertrófica con anomalías renales por mutación del ADN mitocondrialMiocardiopatía hipertrófica con anomalías renales por mutación del ADNmt
itCardiomiopatia ipertrofica con anomalie renali da mutazione del DNA mitocondrialeCardiomiopatia ipertrofica con anomalie dei reni da mutazione del DNA mitocondriale · Cardiomiopatia ipertrofica con anomalie renali da mutazione del mtDNA
nlHypertrofische cardiomyopathie met nieranomalieën door mutatie van mitochondriaal DNAHypertrofische cardiomyopathie met nieranomalieën door mtDNA-mutatie · Hypertrofische cardiomyopathie met renale anomalieën door mutatie van mitochondriaal DNA
ptMiocardiopatia hipertrófica com anomalias renais devido a mutação de ADN mitocondrialMiocardiopatia hipertrófica com anomalias renais devido a mutação no ADNmt
plKardiomiopatia przerostowa i choroba kanalików nerkowych spowodowana mutacjami mitochondrialnego DNAKardiomiopatia przerostowa i choroba kanalików nerkowych z powodu mutacji mtDNA · Kardiomiopatia przerostowa z wadami nerek wskutek mutacji w mitochondrialnym DNA
csHypertrofická kardiomyopatie a renální tubulární nemoc způsobená mutací mitochondriální DNAHypertrofická kardiomyopatie a renální tubulární nemoc způsobená mutací mtDNA
ukГіпертрофічна кардіоміопатія з аномаліями нирок, зумовлена мутацією мітохондріальної ДНКГіпертрофічна кардіоміопатія з аномаліями нирок внаслідок мутації мтДНК · Гіпертрофічна кардіоміопатія з нирковими аномаліями внаслідок мутації мітохондріальної ДНК
zh线粒体DNA突变所致肥厚型心肌病和肾小管性疾病mtDNA突变所致肥厚型心肌病和肾小管性疾病
trMitokondriyal DNA mutasyonuna bağlı hipertrofik kardiyomiyopati ve renal tübüler hastalıkMtDNA mutasyonuna bağlı hipertrofik kardiyomiyopati ve renal tübüler hastalık

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10E88.8NTBTattributedvalidated
ICD-115C53.2YNTBTattributedvalidated
MONDO0017933Evalidated
UMLSC4749942Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (5):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
MT-TL1Disease-causing germline mutation(s) inAssessedHGNC:7490ENSG00000209082590050mitochondriamitochondrially encoded tRNA-Leu (UUA/G) 122781753[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families3 casesWorldwideCase(s)Validated22781753[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

20 annotations · validated 2023-02-08
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0001638Cardiomyopathy
HP:0002059Cerebral atrophy
HP:0012622Chronic kidney disease
HP:0011923Decreased activity of mitochondrial complex I
HP:0003236Elevated circulating creatine kinase concentration
HP:0001508Failure to thrive
HP:0008872Feeding difficulties in infancy
HP:0008947Floppy infant
HP:0001263Global developmental delay
HP:0002151Increased circulating lactate concentration
HP:0001511Intrauterine growth retardation
HP:0002093Respiratory insufficiency
Occasional (29-5%)
HP:00035353-Methylglutaconic aciduria
HP:0011924Decreased activity of mitochondrial complex III
HP:0003348Hyperalaninemia
HP:0002521Hypsarrhythmia
HP:0002490Increased CSF lactate
HP:0001947Renal tubular acidosis
HP:0001250Seizure
HP:0004322Short stature

Annotation source: 22781753[PMID]

7

Sources for this card